Froben Gola throat spray

Froben Gola is a localized analgesic and anti-inflammatory treatment specifically formulated for throat conditions, featuring flurbiprofen as its active ingredient. The brand has a long-standing history in the Italian pharmaceutical market, originally developed by the British company Boots, which pioneered the discovery of ibuprofen-related compounds.

Over the decades, through various corporate mergers and acquisitions, the brand moved from Boots to BASF, then to Knoll, and subsequently to Abbott and Mylan. Today, Froben is part of the Viatris portfolio, a global healthcare company formed through the merger of Mylan and Pfizer's Upjohn division. While the brand has international roots, this specific product is heavily localized and manufactured in Italy to serve the Southern European market.